Posted by Two Blokes
Century Therapeutics (IPSC) could be a great choice for investors looking to buy stocks that have gained stron
Source: Two Blokes Trading
Posted by Two Blokes
JP Morgan has shifted its top pick among gold miners in Europe, the Middle East and Africa, replacing Fresnill
Source: Two Blokes Trading
Posted by Two Blokes
Apple will purchase rare-earth magnets from MP Materials' facility in Texas.
Source: Two Blokes Trading
Posted by Two Blokes
META's stock is nearly up 50% since April low and could hit new highs soon, as markets expect ad spending to h
Source: Two Blokes Trading
Posted by Two Blokes
Wells Fargo & Co (NYSE:WFC, ETR:NWT) on Tuesday reported better-than-expected second-quarter earnings, driven
Source: Two Blokes Trading
Posted by Two Blokes
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losse
Source: Two Blokes Trading
Posted by Two Blokes
PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market press
Source: Two Blokes Trading
Posted by Two Blokes
HBAN's Q2 earnings are likely to have risen on stronger NII and fee income, though higher expenses and credit
Source: Two Blokes Trading
Posted by Two Blokes
Investors need to pay close attention to DEA stock based on the movements in the options market lately.
Source: Two Blokes Trading
Posted by Two Blokes
KO's asset-light bottling shift boosts margins and efficiency, with local focus helping offset global disrupti
Source: Two Blokes Trading
Posted by Two Blokes
Important near-term catalysts for ETON have been eliminated due to insider stock sales and a disappointing par
Source: Two Blokes Trading
Posted by Two Blokes
Lisata Therapeutics Inc (NASDAQ:LSTA) announced that it has been issued a new US composition of matter patent
Source: Two Blokes Trading